2025-09-15 - Analysis Report
Okay, here's the analysis of Colgate-Palmolive (CL) based on the provided data, formatted for a report:

## Colgate-Palmolive (CL) Stock Analysis

**Ticker:** CL
**Company:** Colgate-Palmolive Co.
**Description:** A global consumer products company focused on oral care, personal care, home care, and pet nutrition.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 10.47%
*   **VOO Cumulative Return:** 104.48%
*   **Absolute Divergence:** -81.1%
*   **Relative Divergence:** 0.0% (This means the current divergence is at the very bottom of its historical range relative to VOO)

**Analysis:** CL has significantly underperformed the S&P 500 over the covered period. The relative divergence indicates this underperformance is near its historical worst compared to VOO.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 13.0%  | 4.5%   | -16.0%  | 0.0    | 61.0   |
| 2016-2018  | -11.0% | 65.2%  | -29.0%  | 0.1    | 48.1   |
| 2017-2019  | 7.0%   | 65.2%  | -22.0%  | 0.1    | 55.6   |
| 2018-2020  | 18.0%  | 65.2%  | -2.0%   | 0.6    | 69.1   |
| 2019-2021  | 30.0%  | 58.6%  | -19.0%  | 0.7    | 69.0   |
| 2020-2022  | 7.0%   | 69.0%  | 5.0%    | 0.7    | 63.7   |
| 2021-2023  | 6.0%   | 69.0%  | -12.0%  | 0.8    | 64.4   |
| 2022-2024  | 13.0%  | 69.0%  | -12.0%  | 0.8    | 73.5   |
| 2023-2025  | -3.0%  | 70.6%  | -59.0%  | 0.3    | 67.3   |

**Analysis:** The table indicates a few key points:

*   **Alpha:** Alpha is mostly negative, indicating underperformance relative to the market risk-free rate.  The recent period (2023-2025) shows a particularly large negative alpha.
*   **Beta:** Beta values are generally low (below 1), suggesting CL is less volatile than the market (S&P 500).
*   **MDD:** The Maximum Drawdown (MDD) has been quite high in recent periods.
*   **Cap:** The company's market capitalization is relatively stable.
*   **CAGR:** The Compound Annual Growth Rate(CAGR) is volatile over time

### 2. Recent Price Action

*   **Last Price:** 83.28
*   **Previous Close:** 84.06
*   **Change:** -0.93
*   **5-day Moving Average:** 83.80
*   **20-day Moving Average:** 84.43
*   **60-day Moving Average:** 86.63

**Analysis:** The stock is trading below its 5, 20, and 60-day moving averages, suggesting a short-term downtrend. The recent price decrease of -0.93 from the previous close confirms this downward momentum.

### 3. Technical Indicators & Outlook

*   **Market Risk Indicator (MRI):** 0.32 (Low Risk)
*   **RSI:** 37.14 (Approaching Oversold)
*   **PPO:** 0.04
*   **Hybrid Signal:** Cash 0%, Buy 90% of cash (3 shares - Safe)
*   **20-day Relative Divergence Change:** -3.8 (Negative - indicating short-term decline)
*   **Expected Return (%):** -2655.4% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a low-risk environment for the overall market.
*   The RSI is approaching oversold territory, potentially indicating a buying opportunity *if* other factors align.
*   The negative change in relative divergence and the highly negative expected return further highlight the underperformance compared to the S&P 500 and suggest caution.
*   The Hybrid Signal recommends a buy, likely due to the stock's perceived safety and potential for long-term value.

### 4. Recent News & Events

*   **Positive Sentiment:** Several articles highlight Colgate-Palmolive's stability, dividend payouts, and potential for passive income ("Jim Cramer on Colgate-Palmolive: 'One of the Premier Consumer Packaged Goods'", "Here's How You Can Earn $100 In Passive Income By Investing In Colgate-Palmolive Stock").
*   **Growth Initiatives:** Articles discuss Colgate's productivity program and adoption of AI for biomaterials development ("Can Colgate's New Productivity Program Drive Long-Term Growth?", "Colgate-Palmolive signs on to AI tool for biomaterials development").
*   **Dividend:**  Recent announcements of regular quarterly dividends ("Colgate-Palmolive (CL) Board Declares US$0.52 Quarterly Dividend", "Colgate Declares Regular Quarterly Dividend").

**Analysis:** Recent news presents a mixed picture. While there's positive sentiment surrounding the company's stability, dividend, and initiatives, it's important to weigh this against the negative performance data.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.10)
*   **Target Price:** 95.22 (Average), 106.00 (High), 83.00 (Low)
*   **Recent Rating Changes:** No changes indicated in the provided data.

**Analysis:**  Analysts, on average, have a "Buy" rating with a target price significantly above the current price. However, the low target price is very close to the current price.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-08-01 | 0.92 | 5.11 B$    |
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.9  | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2025-08-01 | 0.89 | 5.06 B$    |

**Analysis:** Revenue and EPS figures have been relatively stable over the past few quarters. There was a slight increase in revenue in the most recent quarter.

### 6. Financial Information: Revenue and Profitability

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $5.11B    | 60.06%        |
| 2025-03-31   | $4.91B    | 60.82%        |
| 2024-12-31   | $4.95B    | 60.30%        |
| 2024-09-30   | $5.03B    | 61.08%        |
| 2024-06-30   | $5.06B    | 60.62%        |

### 6. Financial Information: Capital and Profitability

| Quarter      | Equity   | ROE        |
|--------------|-----------|---------------|
| 2025-06-30   | $0.70B    | 105.84%        |
| 2025-03-31   | $0.36B    | 190.08%        |
| 2024-12-31   | $0.21B    | 348.58%        |
| 2024-09-30   | $0.43B    | 169.43%        |
| 2024-06-30   | $0.12B    | 594.31%        |

**Analysis:**

*   **Revenue:** Revenue has been relatively consistent.
*   **Profit Margin:** Profit margins are consistently high, demonstrating strong profitability.
*   **Equity:** Equity has fluctuated
*   **ROE:** Return on Equity is very high, but it's important to investigate why equity is so low. This could be due to share buybacks or other financial strategies that need further examination.

### 7. Overall Summary

Colgate-Palmolive (CL) presents a mixed investment picture.  While the company demonstrates stability, high profit margins, and a history of dividend payouts, it has significantly underperformed the S&P 500. Recent news suggests the company is pursuing growth initiatives, but technical indicators point to short-term downward pressure.

**Key Considerations:**

*   **Underperformance:** The most significant concern is the substantial underperformance relative to the S&P 500, as reflected in the negative alpha and divergence figures.
*   **Valuation:**  The current price is below the average analyst target price.
*   **Dividends:**  The company's consistent dividend payments may appeal to income-focused investors.
*   **ROE:** High ROE but requires further analysis.
*   **Low Risk:** The MRI suggests a low-risk market.

**Recommendation:**  While the analyst consensus is "Buy", a cautious approach is warranted given the underperformance and negative long-term expected return. Further research is needed to understand the reasons behind the underperformance and whether the company's growth initiatives are likely to reverse this trend. Investors should carefully weigh the dividend yield against the potential for further capital depreciation. Before investing, I'd check why company's ROE is so high.
